Table 1. Demographics.
Patient | Country | Sex | Age | Performance status (WHO) | Tumor stage | Comorbidity | Previous treatment |
1 | Ireland | M | 78 | 2 | T3 N2 M0 | None reported | None |
2 | Ireland | M | 77 | 2 | T4 N2 M0 | Respiratory compromise | Chemotherapy FOLFOX × 4 cycles |
3 | Ireland | F | 74 | 1 | T3 N0 M0 | Early Alzheimers | None |
4 | Ireland | F | 62 | 1 | T4 N0 M0 | None reported | Insulin potentiation therapy |
5 | Denmark | F | 85 | 2 | T2 N0 M0 | Cardiovascular disease (biological aortic valve, pacemaker, arrhythmia, previous apoplexy) | Radiotherapy 5 Gy × 3 |
6 | Denmark | F | 88 | 2 | T2 N0 M0 | Arrhythmia | Argon beam |
7 | Denmark | M | 71 | 1 | T1 N0 M0 | Diabetes, chronic nephropathy Cardiovascular disease (biological aortic valve, pacemaker) | Radiotherapy 1.8 Gy × 25 |
FOLFOX, fluorouracil, leucovorin and oxaliplatin; Gy,Gray.